Tareq Abadl/LinkedIn
Jun 5, 2026, 14:19
Tareq Abadl: The Science of Blood Component Separation and Targeted Transfusion Care
Tareq Abadl, Medical Lab Specialist, shared a post on LinkedIn:
“Same donation. Different components. Different patients. Different lives saved.
Packed RBCs (pRBCs)
- Storage: 1–6°C
- Shelf life: 42 days
- Used for acute and chronic blood loss — raises Hb and maintains tissue oxygenation.
- Trigger: Hb less than 7 g/dL
Fresh Frozen Plasma (FFP)
- Storage: −18°C
- Shelf life: 1 year
- Contains all clotting factors — used to reverse anticoagulant effects and treat coagulopathic bleeding.
- Not for volume expansion alone.
Platelets
- Storage: 20–24°C (with agitation)
- Shelf life: 5 days
- Indicated to prevent hemorrhage in patients with thrombocytopenia or platelet function defects.
- Trigger: Platelets less than 10,000/µL (or less than 100,000 with active bleeding)
Cryoprecipitate
- Storage: −18°C
- Shelf life: 1 year
- Contains high concentrations of Factor VIII and fibrinogen — used in hypofibrinogenemia, DIC, and massive hemorrhage.
- Also used in Hemophilia A and Von Willebrand Disease
Golden Rule:
The basic principle of blood component therapy is to prescribe only the specific product the patient needs — one whole blood donation can be separated to benefit several recipients with different needs.”

Other posts featuring Tareq Abadl on Hemostasis Today.
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines
-
Nov 15, 2026, 20:50Asmaa Beltagy: Efficacy and Safety of Eltrombopag in SLE-Associated Immune Thrombocytopenia
-
Nov 15, 2026, 16:29Jean-Jacques Kiladjian: 20 Years of Interferon-Alpha Research in Myeloproliferative Neoplasms
-
Nov 15, 2026, 16:21Sukanto Paul: Why Platelet Transfusion Is Generally Avoided in TTP
-
Nov 15, 2026, 16:14Ahmad G. Alzahrani: Major Bleeding and Anticoagulant Reversal
-
Nov 15, 2026, 16:05Sabine Eichinger: Is Recurrence Risk After Provoked VTE Really Low?